Legend Biotech's market cap is currently ―. The company's EPS TTM is $-2.952; its P/E ratio is -18.60; Legend Biotech is scheduled to report earnings on May 15, 2024, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	-	-	$ 11.97M	$ 40.83M	$ 38.99M
Gross Profit	-	-	$ -4.97M	-	-
EBIT	-	-	$ -191.43M	$ -40.09M	$ -87.73M
EBITDA	-	-	$ -191.43M	$ -36.17M	$ -84.02M
Net Income Common Stockholders	-	-	$ -193.23M	$ -41.09M	$ -88.33M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.28B	$ 786.03M	$ 783.11M	$ 791.26M	$ 882.39M
Total Assets	$ 1.85B	$ 1.33B	$ 1.02B	$ 1.04B	$ 1.12B
Total Debt	$ 383.94M	$ 284.53M	$ 195.72M	$ 129.23M	$ 122.97M
Net Debt	$ -893.77M	$ -501.50M	$ -587.39M	$ -662.03M	$ -759.43M
Total Liabilities	$ 597.24M	$ 1.33B	$ 460.11M	$ 601.95M	$ 647.16M
Stockholders Equity	$ 1.25B	$ 744.31M	$ 562.63M	$ 438.56M	$ 471.21M
Cash Flow	-
Free Cash Flow	-	-	-	$ -91.22M	$ -72.70M
Operating Cash Flow	-	-	-	$ -78.69M	$ -69.55M
Investing Cash Flow	-	-	-	$ -232.50M	$ 96.51M
Financing Cash Flow	-	-	-	$ 25.00K	$ 323.56M

Currency in USD

Legend Biotech Earnings and Revenue History

Income Statement >

Legend Biotech Debt to Assets

Balance Sheet >

Legend Biotech Cash Flow

Cash Flow >

Legend Biotech Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing